1. Home
  2. PRAX vs SIRI Comparison

PRAX vs SIRI Comparison

Compare PRAX & SIRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Praxis Precision Medicines Inc.

PRAX

Praxis Precision Medicines Inc.

HOLD

Current Price

$292.00

Market Cap

9.6B

Sector

Health Care

ML Signal

HOLD

Logo Sirius XM Holdings Inc.

SIRI

Sirius XM Holdings Inc.

HOLD

Current Price

$22.03

Market Cap

7.3B

ML Signal

HOLD

Company Overview

Basic Information
Metric
PRAX
SIRI
Founded
2015
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
9.6B
7.3B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
PRAX
SIRI
Price
$292.00
$22.03
Analyst Decision
Strong Buy
Hold
Analyst Count
15
8
Target Price
$572.13
$25.00
AVG Volume (30 Days)
321.1K
3.4M
Earning Date
01-01-0001
05-07-2026
Dividend Yield
N/A
4.86%
EPS Growth
N/A
136.32
EPS
N/A
2.23
Revenue
N/A
$5,425,129,000.00
Revenue This Year
N/A
$1.81
Revenue Next Year
$6,395.88
$0.65
P/E Ratio
N/A
$9.97
Revenue Growth
N/A
8.13
52 Week Low
$26.70
$18.69
52 Week High
$354.87
$24.55

Technical Indicators

Market Signals
Indicator
PRAX
SIRI
Relative Strength Index (RSI) 37.08 55.10
Support Level $290.36 $22.02
Resistance Level $322.32 $22.54
Average True Range (ATR) 17.42 0.53
MACD -5.25 0.01
Stochastic Oscillator 7.97 59.95

Price Performance

Historical Comparison
PRAX
SIRI

About PRAX Praxis Precision Medicines Inc.

Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. It is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company applies genetic insights to the discovery and development of therapies for neurological disorders through two proprietary platforms: Cerebrum and Solidus. It has established a diversified, multimodal CNS portfolio with four clinical-stage product candidates across movement disorders and epilepsy, which include Ulixacaltamide, Relutrigine, Vormatrigine, and Elsunersen. The firm operates in only one segment and is focused on discovering and developing therapies for CNS disorders.

About SIRI Sirius XM Holdings Inc.

SiriusXM operates almost exclusively in the US through its SiriusXM and Pandora audio services. SiriusXM is primarily a satellite radio service that offers nationwide coverage and mostly ad-free listening, with proprietary channels and exclusive content. It makes agreements with automakers to install its radios in vehicles and give trial services to vehicle buyers, which have traditionally fed its subscriber base. The company provides the service via a fleet of geostationary satellites it owns and operates, and now offers a streaming SiriusXM option. Pandora, which accounts for a much smaller portion of revenue and profit, offers a subscription and ad-supported streaming music service that competes with industry giants such as Spotify, Apple Music, and YouTube Music.

Share on Social Networks: